Mirae Asset Global Investments’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$66.2K Buy
2025
Q1
$40.6K Buy
2024
Q4
$34.9K Sell
2024
Q3
$50.2K Buy
2024
Q2
$23.3K Buy
2024
Q1
Sell
2023
Q4
$90.6K Buy
2023
Q3
$61.9K Buy
2023
Q2
$109K Buy